Celgene

Celgene is a top pharmaceutical company, incorporated in Delaware and headquartered in Summit, New Jersey

Celgene is a top pharmaceutical company, incorporated in Delaware and headquartered in Summit, New Jersey.The company was born in 1986 as a spin out from Celanese Corporation, following the merger of Celanese Corporation with American Hoechst Corporation.Celgene is primarily engaged in the discovery, development and commercialization of innovative therapies to treat cancer and immune-inflammatory diseases in patients with limited treatment options worldwide.

Report: Partnering Deals and Alliances with Celgene

Celgene is a top pharmaceutical company, incorporated in Delaware and headquartered in Summit, New Jersey.

The company was born in 1986 as a spin out from Celanese Corporation, following the merger of Celanese Corporation with American Hoechst Corporation.

Celgene is primarily engaged in the discovery, development and commercialization of innovative therapies to treat cancer and immune-inflammatory diseases in patients with limited treatment options worldwide.

Celgene has a wide range of test compounds which are in being evaluated in their clinical stages at various major medical centres.

Celgene’s main focus is to discover and develop investigational compounds for treating patients with incurable haematological and solid tumour cancers, including:

Celgene is also actively involved in finding therapies for  inflammatory diseases like psoriasis and psoriatic arthritis.

Celgene has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Celgene has a long history of partnering, building numerous collaborative partnerships more

Celgene announced over 36 partnering / licensing deals since 2005, with an increase in collaborations being signed since the onset of this deacde. Analysis of the partnering deals shows a strong emphasis on partnerships in cancer and inflammatory diseases more

Celgene has also announced 5 M&A deals since 2005, with the lead deals being the acquisition of Pharmion Corporation and Abraxis Bioscience more

Report: Partnering Deals and Alliances with Celgene

Examples of recent partnering and licensing deals announced by Celgene can be viewed in Current Partnering's Celgene partnering activity review article.

Examples of recent M&A deals announced by Celgene can be viewed in Current Partnering's Celgene M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Celgene

See also

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Celgene

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Celgene

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Celgene company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email